Kyle T. Bradley, MD, MS, is board certified in anatomic and clinical pathology and hematopathology. Dr. Bradley serves as associate professor in the Department of Pathology and Laboratory Medicine at Emory University School.
Dr. Bradley received his Medical Degree and Master of Science from University of Missouri-Columbia in Columbia, Missouri. He completed his pathology residency and hematopathology fellowship at Emory University School of Medicine in Atlanta, Georgia.
Titles & Roles
Associate Professor, Department of Pathology and Laboratory Medicine
Emory University School of Medicine
Associate Vice-Chair of Anatomic Pathology, Department of Pathology and Laboratory Medicine
Emory University School of Medicine
Director of Surgical Pathology, Department of Pathology and Laboratory Medicine
Emory University School of Medicine
Education & Training
Education
Fellowship, Pathology-Anatomic, 2010
Vanderbilt University Medical Center
Fellowship, Hematopathology, 2009
Emory University School of Medicine
Residency, Anatomic & Clinical Pathology, 2008
Emory University School of Medicine
Internship, Anatomic & Clinical Pathology, 2005
Emory University School of Medicine
Medical Education, MD, 2004
University of Missouri - Columbia
Board Certifications
Hematopathology
American Board of Pathology, 2009
Anatomic Pathology
American Board of Pathology, 2008
Clinical Pathology
American Board of Pathology, 2008
Research
Dr. Bradley's research interests are primarily focused on pathology education and improving communication in the fields of hematopathology and surgical pathology, with an emphasis on improved cancer reporting. In addition, he is interested in applications of ancillary studies, particularly immunophenotyping, in the diagnosis of benign and neoplastic lymphoproliferative disorders.
Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care.
Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to
all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations
behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful
for our patients, please click here.